Navigation Links
Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
Date:10/23/2008

uccessfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.


'/>"/>
SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
2. Oncolytics Biotech Inc. Collaborators to Present Preclinical Combination REOLYSIN(R) and Cisplatin Research at EORTC-NCI-AACR Annual Meeting
3. Media Advisory - Oncolytics Biotech Inc. to Present at BIO Investor Forum 2008
4. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
5. Oncolytics Biotech Inc. Completes Initial Scale Up of Manufacturing Process for REOLYSIN(R) to Commercial Scale
6. Media Advisory - Oncolytics Biotech Inc. to Present at Maxim Group Growth Conference
7. Oncolytics Biotech Inc. Announces Issuance of 28th U.S. Patent
8. Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Clinical Trial
9. Oncolytics Biotech Inc. Starts Patient Enrolment in U.S. Phase 2 Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
10. /R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/
11. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... announced that data from pre-clinical studies of its IL-3R targeting ... and animal models of human chronic myeloid leukemia (CML) have ... Meeting of the American Society of Hematology (ASH), to be ... will be presented by Stemline,s collaborators at The University of ...
(Date:12/3/2009)... ACCESS PHARMACEUTICALS, INC. (OTC Bulletin ... commercial launch of MuGard, an FDA approved treatment for ... and chemotherapy. MuGard is commercially launched by Access, partner, ... Italy, Norway, Greece and Sweden. Access is conducting pre-marketing ...
(Date:12/3/2009)... Inc. (NYSE: IMA ), a global leader in ... through the merger of rapid diagnostics and health management, has ... B Convertible Perpetual Preferred Stock ( IMA-PB). The dividend will ... amount per share equal to the quotient of (a) $3.00 ...
(Date:12/2/2009)... emerging as one of the fastest growing green energy companies ... Group and True Green Planet,s President and Recycling Specialist Leroy ... 25 years, stated that Spectrum Blue Steel is light years ... earnings because of the bi products recovered by using the ...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3
... Chairman and Chief Executive Officer James G. Carlson released ... Health Insurance Program (SCHIP), which was signed yesterday by ... start in life, and that happens only when they ... the healthcare they need. President Obama and Congress ...
... Feb. 5 /PRNewswire-FirstCall/ - Dr. Brad Thompson, President and ... ONCY ), will present a corporate overview of ... Conference on Monday, February 9, 2009 at 4:30 p.m. ... Bayshore Resort in Vancouver, B.C. from February 8-10, 2009.About ...
... Feb. 5 As states increase the number of ... developing new ways of integrating academic content with content ... One trend that is emerging is the state and ... career and technical education (CTE) courses. A new paper ...
Other Biology Technology:AMERIGROUP Praises Expansion of State Children's Health Insurance Program (SCHIP) 2Media Advisory - Oncolytics Biotech(R) Inc. to Present at BioPartnering North America 2ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes 2ACTE Releases Paper Highlighting Policy Trend to Support Recognition of Academic Credit for CTE Classes 3
(Date:12/3/2009)... BIO-key International, Inc. (OTC Bulletin Board: BKYI), ... biometric identification solutions, announced that a majority of ... today approved the sale of the company,s Law ... the shares voted, 98.6% were cast in favor ...
(Date:12/3/2009)... , Preliminary Press Conference Topics, Last Call! ... museum, Attention PIOs: Sending Press Releases to Fall ... December, News Media registration information , News Media ... Who,s coming, , For important information regarding ...
(Date:12/3/2009)... social snubbing? Your genetics, not your friends, may be at ... opioids, relieve not only physical pain, but also some forms ... of 1000 Biology member Markus Heilig shows that small genetic ... the intensity of people,s responses to social rejection. , ...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6Drug Limits Stomach Trouble in Patients Taking Low Dose Aspirin 50780 1Drug Limits Stomach Trouble in Patients Taking Low Dose Aspirin 50780 2New study pinpoints difference in the way children with autism learn new behaviors 50778 1New study pinpoints difference in the way children with autism learn new behaviors 50778 2New study pinpoints difference in the way children with autism learn new behaviors 50778 3Atrial fibrillation linked to increased hospitalization in heart failure patients 50776 1Atrial fibrillation linked to increased hospitalization in heart failure patients 50776 2
... Hospital (MGH) researchers have developed a new type of ... greatly expand the application of minimally invasive diagnostic and ... Nature, the team from the Wellman Center for Photomedicine ... of its use in a mouse model. ...
... facial similarity of children is effectively an estimate of ... according to a new study recently published in Journal ... Association for Research in Vision and Ophthalmology (ARVO). ... of children, half of which portrayed actual siblings. ...
... varying the length of daylight to which mice are exposed ... , The study found that in the short days ... increase aggression in males of a particular type of mouse ... in the long days of summer, estrogen decreases aggression among ...
Other Biology News:Three-dimensional, miniature endoscope opens new diagnostic possibilities 2Changing length of days reverses how estrogen affects aggressiveness in mice 2Changing length of days reverses how estrogen affects aggressiveness in mice 3Changing length of days reverses how estrogen affects aggressiveness in mice 4
...
...
... The newest member of Wyatt Technology's family ... inside of your high temperature chromatograph and ... data from thermoplastic polymers. The HTmD is ... Waters 150C, PL220C or Alliance 2000 device ...
...
Biology Products: